Investment Summary |
|
|---|---|
| Date | 2021-06-29 |
| Target | Hikari |
| Sector | Manufacturing |
| Investor(s) | T Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1991 |
| PE ASSETS | 220.0B JPY |
| Size | Large |
| Type | Sector Agnostic |
T Capital Partners is a private equity firm focused on buyout and venture transactions in Japan. Within buyouts, the Firm looks to acquire controlling interests in established mid-cap companies with steady growth and strong market positions. T Capital will consider opportunities in a variety of sectors and generally partners with management when pursuing transactions. T Capital Partners was formed in 1991 and is based in Tokyo.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 28 |
| Sector: Manufacturing M&A | 1 of 1 |
| Type: Growth Capital M&A Deals | 5 of 8 |
| Country: Japan M&A | 23 of 28 |
| Year: 2021 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-31 |
WITH
Saitama, Japan WITH operates childcare facilities, primarily in the Tokyo, Saitama, and Kanagawa areas. The company provides various services for people who need care for their families, guidance for pre-school learnings, and a smooth transition back to work after a baby care. WITH is based in Saitama, Japan. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-12 |
MicroBiopharm Japan
Tokyo, Japan MicroBiopharm Japan is a Contract Development Manufacturing Organization ("CDMO") with strengths in microbial fermentation technology, engaged in the contract manufacturing and development of active pharmaceutical ingredients ("APIs") and the manufacture and sale of its own APIs. MicroBiopharm Japan was founded in 2011 and is based in Tokyo, Japan. |
Buy | - |
